- Top Workplaces
- Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer.
Purpose
Our unwavering belief in patients fuels every breakthrough we achieve. With grit and determination as our driving forces, we’re determined to redefine what’s possible and bring hope to countless lives.
Our novel approach to cancer treatment involves targeting the export of specific proteins in a cancer cell’s nucleus with SINE technology (Selective Inhibition of Nuclear Export).
Our novel approach to cancer treatment involves targeting the export of specific proteins in a cancer cell’s nucleus with SINE technology (Selective Inhibition of Nuclear Export).
Vision
From the moment a patient receives a cancer diagnosis, every second counts. We feel that sense of urgency and put it into action in our day-to-day work. To ensure our efforts are focused on areas that will make the biggest impact for patients, we collaborate every step of the way to understand what's most important to them.
Time is precious. It’s not just about providing cancer patients with extra days or years, it’s about the quality of that time. The therapies we’re developing have the potential to change the experience and life trajectory of patients and give them more milestones to cherish.
We are dedicated to getting it right for patients. This means better understanding their journey and how they define “right.” To honor this dedication, we don’t settle. We partner with others who can help advance the patient experience, we re-examine our approaches, and we keep going until we deliver what’s best for patients.
Time is precious. It’s not just about providing cancer patients with extra days or years, it’s about the quality of that time. The therapies we’re developing have the potential to change the experience and life trajectory of patients and give them more milestones to cherish.
We are dedicated to getting it right for patients. This means better understanding their journey and how they define “right.” To honor this dedication, we don’t settle. We partner with others who can help advance the patient experience, we re-examine our approaches, and we keep going until we deliver what’s best for patients.
Mission
As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, and myelofibrosis.
At Karyopharm, we support a culture of innovation, courage, alignment and accountability, resiliency and energy with our employees and collaborators. Integrity and respect are core to our success.
At Karyopharm, we support a culture of innovation, courage, alignment and accountability, resiliency and energy with our employees and collaborators. Integrity and respect are core to our success.
Additional Culture Details
If you want to do something that matters, this work matters. Patients drive our passion to pioneer novel cancer therapies. That’s why we’ve built an environment centered around support, flexibility, and a shared mission.
Creating and delivering medicine for cancer can only be done through focus, dedication, and heart. We hire exceptional people and trust each other to work in whatever way lets us, be us – whether that’s onsite, from home, or anywhere in between.
Creating and delivering medicine for cancer can only be done through focus, dedication, and heart. We hire exceptional people and trust each other to work in whatever way lets us, be us – whether that’s onsite, from home, or anywhere in between.
Values
- Innovation
- We challenge the status quo when the current thinking no longer provides the best solution for our patients. We innovate with purpose and draw from diverse experiences.
Headquarters
Newton, MA
Employees
315 US Employees
Industry
Pharmaceuticals
Recent Awards
2024